Press + news
Codex DNA Announces Launch of Initial Public Offering
SAN DIEGO, Calif., June 14, 2021 (GLOBE NEWSWIRE) — Codex DNA, Inc. (“Codex DNA”), creators of the BioXp™ system, a fully automated benchtop instrument that enables numerous synthetic biology workflows, today announced the launch of its public offering of 6.7…
Codex DNA Releases Long Gene Fragment Cloning On The BioXp™ System
San Diego, CA, May 04, 2021 – Codex DNA, Inc., creators of the BioXp™ system, a fully automated benchtop instrument that enables numerous synthetic biology workflows, announced the addition of longer fragment cloning to the BioXp™ system. Scientists are now…
Codex DNA Expands End-to-End Automated Synthetic Biology Workstation Enabling High Throughput Synthesis from DNA Sequence to Biologically Active mRNA
SAN DIEGO — April 27, 2021 — Codex DNA, Inc., creators of the BioXp™ system, a fully automated benchtop instrument that enables numerous synthetic biology workflows, today announced the release of a mRNA workflow for the BioXp™ workstation allowing scientists…
Codex DNA Releases World’s First Synthetic Genomes for Emerging SARS-CoV-2 Variants
SAN DIEGO — March 5, 2021 — Codex DNA, Inc., today announced the release of the world’s first full-length synthetic genomes for two emerging variants of the SARS-CoV-2 virus. The new genomes include the B.1.1.7 variant that initially emerged in…
Codex DNA Releases New Synthetic Genomes for the Fight Against COVID-19
SAN DIEGO – (GLOBE NEWSWIRE) – Codex DNA, Inc. today announced the release of seven new synthetic SARS-CoV-2 genomes for use in the development of vaccines, therapeutics, and diagnostics to help in the COVID-19 pandemic response. With our BioXp™ 3250 system,…
Codex DNA Demonstrates Momentum Toward Mission of Building World’s First Vaccine Printer and Global Vaccine Network
SAN DIEGO – (GLOBE NEWSWIRE) – Codex DNA, Inc., creators of the world’s first fully automated system for high-throughput writing of DNA, today announced critical advancements in its development of the Digital-to-Biological Converter™ (DBC) platform. The platform will enable the direct…
Codex DNA Launches New Automated Synthetic Biology Workstation for Commercial Use
SAN DIEGO – (GLOBE NEWSWIRE) – Today, Codex DNA, Inc., creators of the world’s first fully automated system for high-throughput DNA printing, announced the introduction of their next-generation platform, the BioXp™ 3250 system. This system reduces the timelines for identifying vaccine and…
Codex DNA Releases New Synthetic SARS-CoV-2 Genome for COVID-19 Vaccine and Therapeutic Research
SAN DIEGO – (GLOBE NEWSWIRE) – Codex DNA, Inc., today announced the release of a new synthetic SARS-CoV-2 genome developed to accelerate research on the latest and the most dominant strain of the SARS-CoV-2 virus responsible for the COVID-19 pandemic. The…
Codex DNA announces 8 new products to support the scientific community’s battle against COVID-19
SAN DIEGO – (GLOBE NEWSWIRE) – Codex DNA, Inc., creators of the world’s first fully automated system for high-throughput writing of DNA, the BioXp™ 3200 system, today announced a newly developed and released suite of products and services designed to accelerate…
SGI-DNA is now Codex DNA
SAN DIEGO – (GLOBE NEWSWIRE) – SGI-DNA, Inc., creators of the world’s first fully automated system for high-throughput writing of DNA, the BioXp™ 3200 system, today announced the business rebrand to Codex DNA, Inc. The rebrand signifies and solidifies the company’s…
SGI-DNA Equipping Researchers With Critical Tools to Combat Coronavirus Disease (COVID-2019)
SAN DIEGO – (BUSINESS WIRE) – SGI-DNA, creators of the BioXp™ 3200 System and Gibson Assembly® Reagents, announces a focused effort to empower organizations to accelerate research focused on creating vaccines for SARS-CoV-2. SGI-DNA is building resources to support partners in the…
SGI-DNA Launches Vmax™ X2, the Most Innovative Product in the Competent Cells Market Since the Discovery of E. coli
SAN DIEGO – (BUSINESS WIRE) – SGI-DNA, creators of the BioXp™ 3200 System and Gibson Assembly® Reagents, has launched Vmax™ X2 Competent Cells, designed to generate two to four times more soluble protein in half of the time of current methods…
SGI-DNA Appoints Brian Donnelly as Chief Commercial Officer
SAN DIEGO – (BUSINESS WIRE) – SGI-DNA, Inc., a company dedicated to developing transformative synthetic genomics technologies and revolutionary DNA data storage solutions, today announced the appointment of Brian Donnelly to the newly created position of Chief Commercial Officer. Mr. Donnelly…
SGI-DNA Launches Gibson Assembly® RapidAMP™ Technology for its BioXp™ Gene Builder
SAN DIEGO – (BUSINESS WIRE) – SGI-DNA announces the launch of Gibson Assembly® RapidAMP™ technology—a novel approach that allows for cell-free synthesis and amplification of transfection-ready quantities of synthetic DNA. The application has been integrated onto the BioXp™ 3200 Gene Builder and…
Gibson Assembly® Advances Field of DNA Digital Data Storage
SAN DIEGO – (BUSINESS WIRE) – Researchers from the University of Washington and Microsoft announced a DNA assembly strategy for nanopore data storage, reporting that the Gibson Assembly® Method was exceptionally effective in retrieving information stored in DNA. The strategy successfully…
SGI-DNA Secures $25 Million Series A Financing to Support Commercial Launch
SAN DIEGO – (BUSINESS WIRE) – SGI-DNA, a company dedicated to developing transformative synthetic genomics technologies and revolutionary DNA data storage solutions, has completed a $25 million Series A financing round led by Northpond Ventures, with participation from Oxford Finance…
SGI-DNA Launches Multi-Tile Assembly Cloning (MTAC) Application for its BioXp™ 3200
SAN DIEGO – (BUSINESS WIRE) – SGI-DNA announces the launch of the Multi-Tile Assembly Cloning (MTAC) application for its BioXp™ 3200 Gene Builder, providing scientists with the ability to synthesize two genes and clone them with an optional constant fragment…